| Price | 1,337.00on 18-07-2018 at 16:30:00 |
|---|---|
| Change | 3.00 0.22% |
| Buy | 1,337.00 |
| Sell | 1,336.50 |
| Buy / Sell SN. Shares | |
| Last Trade: | Sell 114 at 1,336.00p |
| Day's Volume: | 796,384 |
| Last Close: | 1,334.00p |
| Open: | 1,337.00p |
| ISIN: | GB0009223206 |
| Day's Range | 1,333.00p - 1,351.00p |
| 52wk Range: | 1,173.00p - 1,442.00p |
| Market Capitalisation: | £11,693m |
| VWAP: | 1,335.304p |
| Shares in Issue: | 875m |
Sector: Health Care Equipment & Services
Listed in: FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Recent Trades History Smith & Nephew (SN.) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 114 | 1,336.00 | Automatic Execution | 14:18:35 - 18-Jul-18 |
| Sell* | 123 | 1,336.00 | Automatic Execution | 14:18:27 - 18-Jul-18 |
| Unknown* | 139 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Sell* | 72 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Unknown* | 225 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Sell* | 475 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Sell* | 161 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Sell* | 164 | 1,336.50 | Automatic Execution | 14:18:01 - 18-Jul-18 |
| Buy* | 121 | 1,336.50 | Automatic Execution | 14:17:39 - 18-Jul-18 |
| Buy* | 201 | 1,336.50 | Automatic Execution | 14:17:39 - 18-Jul-18 |
Share Price History for Smith & Nephew |
|||||
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 17th Jul 2018 (Tue) | 1,323.50 | 1,339.00 | 1,317.50 | 1,332.00 | 2,521,046 |
| 16th Jul 2018 (Mon) | 1,345.00 | 1,352.00 | 1,329.50 | 1,345.00 | 1,150,873 |
| 13th Jul 2018 (Fri) | 1,344.50 | 1,351.50 | 1,344.50 | 1,344.50 | 1,419,449 |
| 12th Jul 2018 (Thu) | 1,338.50 | 1,350.00 | 1,337.00 | 1,334.50 | 1,649,139 |
| 11th Jul 2018 (Wed) | 1,332.50 | 1,342.50 | 1,325.50 | 1,338.00 | 1,816,039 |
| 10th Jul 2018 (Tue) | 1,329.00 | 1,343.00 | 1,326.50 | 1,328.50 | 1,560,889 |
| 9th Jul 2018 (Mon) | 1,319.50 | 1,331.50 | 1,317.50 | 0.00 | 1,700,657 |
| 6th Jul 2018 (Fri) | 1,325.50 | 1,329.50 | 1,315.00 | 0.00 | 1,608,350 |
| 5th Jul 2018 (Thu) | 1,313.00 | 1,320.50 | 1,309.50 | 0.00 | 1,904,014 |
| 4th Jul 2018 (Wed) | 1,324.50 | 1,331.00 | 1,301.50 | 0.00 | 2,144,111 |
| 3rd Jul 2018 (Tue) | 1,342.50 | 1,346.00 | 1,319.50 | 0.00 | 4,000,127 |
| 2nd Jul 2018 (Mon) | 1,394.50 | 1,398.00 | 1,334.00 | 0.00 | 4,084,487 |
| 29th Jun 2018 (Fri) | 1,401.50 | 1,407.50 | 1,395.50 | 1,395.00 | 2,607,802 |
| 28th Jun 2018 (Thu) | 1,399.50 | 1,408.00 | 1,387.50 | 1,400.00 | 2,253,406 |
| 27th Jun 2018 (Wed) | 1,392.00 | 1,400.00 | 1,380.00 | 1,392.50 | 3,020,826 |
| 26th Jun 2018 (Tue) | 1,393.00 | 1,394.50 | 1,386.50 | 1,386.50 | 1,243,970 |
| 25th Jun 2018 (Mon) | 1,391.50 | 1,399.50 | 1,381.50 | 1,395.50 | 1,891,985 |
| 22nd Jun 2018 (Fri) | 1,384.00 | 1,398.50 | 1,372.00 | 1,376.00 | 6,059,383 |
| 21st Jun 2018 (Thu) | 1,384.00 | 1,398.50 | 1,372.00 | 1,376.00 | 6,059,383 |
| 20th Jun 2018 (Wed) | 1,369.50 | 1,387.50 | 1,368.00 | 1,361.50 | 2,395,041 |
| 19th Jun 2018 (Tue) | 1,348.50 | 1,365.00 | 1,342.00 | 1,352.00 | 3,429,308 |
| 18th Jun 2018 (Mon) | 1,363.50 | 1,364.00 | 1,348.00 | 1,367.50 | 1,724,544 |
Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.
Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.
News - Sunday, July 20, 2014
The FTSE 100 has gotten off to a slow start this year, but Chris Burvill, manager of the Henderson Cautious Managed Fund, believes that the index could hit unprecedented highs in the second half of this year, potentially breaking the 7,500 barrier....
News - Friday, May 23, 2014
The FTSE 100 fell slightly on Thursday, following mixed economic signals from China, France and the USA. The UK’s leading index closed down b 0.48 points, at 6,820.56, as mining shares boosted the index during a see-saw trading day....
